Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review.
cancer
chemotherapy
nanotechnology
nutraceutical
nutrition
prostate cancer
supplements
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
04
2022
accepted:
25
05
2022
entrez:
29
7
2022
pubmed:
30
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
There are more than two hundred fifty different types of cancers, that are diagnosed around the world. Prostate cancer is one of the suspicious type of cancer spreading very fast around the world, it is reported that in 2018, 29430 patients died of prostate cancer in the United State of America (USA), and hence it is expected that one out of nine men diagnosed with this severe disease during their lives. Medical science has identified cancer at several stages and indicated genes mutations involved in the cancer cell progressions. Genetic implications have been studied extensively in cancer cell growth. So most efficacious drug for prostate cancer is highly required just like other severe diseases for men. So nutraceutical companies are playing major role to manage cancer disease by the recommendation of best natural products around the world, most of these natural products are isolated from plant and mushrooms because they contain several chemoprotective agents, which could reduce the chances of development of cancer and protect the cells for further progression. Some nutraceutical supplements might activate the cytotoxic chemotherapeutic effects by the mechanism of cell cycle arrest, cell differentiation procedures and changes in the redox states, but in other, it also elevate the levels of effectiveness of chemotherapeutic mechanism and in results, cancer cell becomes less reactive to chemotherapy. In this review, we have highlighted the prostate cancer and importance of nutraceuticals for the control and management of prostate cancer, and the significance of nutraceuticals to cancer patients during chemotherapy.
Identifiants
pubmed: 35903701
doi: 10.3389/fonc.2022.925379
pmc: PMC9315356
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
925379Informations de copyright
Copyright © 2022 Chopra, Bibi, Goyal, Gautam, Trivedi, Upadhyay, Mujahid, Shah, Haris, Khot, Gopan, Singh, Kim, Jose, Abdel-Daim, Alhumaydhi, Emran and Kim.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):638-46
pubmed: 21335507
J Biol Chem. 1998 May 29;273(22):13375-8
pubmed: 9593664
Mater Sci Eng C Mater Biol Appl. 2021 May;124:112078
pubmed: 33947570
Nutr Cancer. 2020;72(4):672-685
pubmed: 31402717
Nutrients. 2021 Oct 23;13(11):
pubmed: 34836005
Mol Med Rep. 2015 Mar;11(3):2125-8
pubmed: 25394789
Int J Biochem Mol Biol. 2012;3(4):328-51
pubmed: 23301199
Eur J Pharm Biopharm. 2017 May;114:108-118
pubmed: 28131717
Chin J Integr Med. 2018 Feb;24(2):109-116
pubmed: 28578487
Vitam Horm. 2002;65:127-47
pubmed: 12481545
Anticancer Agents Med Chem. 2009 Feb;9(2):185-211
pubmed: 19199864
J Nutr Biochem. 2013 Oct;24(10):1724-34
pubmed: 23746934
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43
pubmed: 23872180
Med Clin North Am. 2020 Nov;104(6):1051-1062
pubmed: 33099450
Prostate Cancer Prostatic Dis. 2009;12(4):325-32
pubmed: 19901932
Iran J Pharm Res. 2017 Summer;16(3):868-879
pubmed: 29201078
N Engl J Med. 2013 Jul 18;369(3):213-23
pubmed: 23863050
J Control Release. 2019 Jun 10;303:130-150
pubmed: 31022431
Molecules. 2021 Aug 18;26(16):
pubmed: 34443593
Aging (Albany NY). 2017 Jun 12;9(6):1477-1536
pubmed: 28611316
Cancer Metastasis Rev. 2010 Sep;29(3):383-94
pubmed: 20711635
Cancer. 1989 Aug 1;64(3):598-604
pubmed: 2743254
Mater Sci Eng C Mater Biol Appl. 2021 Feb;121:111835
pubmed: 33579473
Prostate. 2013 Nov;73(15):1681-9
pubmed: 23999913
Cancer Causes Control. 2012 Jul;23(7):1163-71
pubmed: 22674291
Metabolism. 2016 Feb;65(2):124-39
pubmed: 26773935
Anticancer Res. 2009 Oct;29(10):3867-75
pubmed: 19846921
Mol Nutr Food Res. 2013 Nov;57(11):2079-85
pubmed: 23766098
Expert Rev Anticancer Ther. 2005 Oct;5(5):847-54
pubmed: 16221054
Int J Oncol. 2009 May;34(5):1221-30
pubmed: 19360335
Eur Urol. 2005 Apr;47(4):449-54; discussion 454-5
pubmed: 15774240
Cancer Prev Res (Phila). 2018 Jun;11(6):337-346
pubmed: 29545400
J Cell Biochem. 2006 Oct 1;99(2):333-44
pubmed: 16518832
Sci Rep. 2019 Mar 13;9(1):4367
pubmed: 30867440
Cells. 2022 Mar 22;11(7):
pubmed: 35406634
Biomolecules. 2019 May 06;9(5):
pubmed: 31064104
Chem Phys Lipids. 2016 Jun;198:51-60
pubmed: 27234272
Int J Biol Macromol. 2015 Nov;81:877-90
pubmed: 26391597
Anal Chem. 2022 Mar 29;94(12):5106-5112
pubmed: 35289593
Nutrients. 2019 Oct 05;11(10):
pubmed: 31590362
Br J Cancer. 2017 Nov 7;117(10):1518-1528
pubmed: 28926527
Biochem Pharmacol. 2012 Nov 15;84(10):1277-81
pubmed: 22842629
Curr Med Chem. 2011;18(31):4786-812
pubmed: 21919847
J Control Release. 2016 Dec 28;244(Pt A):63-73
pubmed: 27840166
Sci Rep. 2018 Jun 4;8(1):8537
pubmed: 29867083
Cancer Causes Control. 2008 Mar;19(2):175-81
pubmed: 18027095
Nanoscale Res Lett. 2018 Feb 07;13(1):44
pubmed: 29417375
Int J Mol Med. 2007 Jan;19(1):165-72
pubmed: 17143561
Materials (Basel). 2018 Jul 06;11(7):
pubmed: 29986436
Carcinogenesis. 2014 Feb;35(2):415-23
pubmed: 24072771
Biomed Pharmacother. 2018 Mar;99:354-362
pubmed: 29358128
Nanomedicine. 2015 Apr;11(3):543-57
pubmed: 25555353
Environ Sci Pollut Res Int. 2020 Nov;27(31):38446-38471
pubmed: 32761528
Int J Oncol. 2002 Oct;21(4):825-30
pubmed: 12239622
Nutr Cancer. 2010;62(5):668-81
pubmed: 20574928
J Nutr. 2005 Aug;135(8):2050S-2S
pubmed: 16046739
Colloids Surf B Biointerfaces. 2021 Jul;203:111723
pubmed: 33839474
Drug Discov Today. 2003 Jun 1;8(11):482-3
pubmed: 12818515
Biochem Biophys Res Commun. 2014 Jul 18;450(1):697-703
pubmed: 24946211
Oncotarget. 2017 Aug 24;8(44):77181-77194
pubmed: 29100379
PLoS One. 2013 Aug 01;8(8):e70372
pubmed: 23936419
Clin Genitourin Cancer. 2013 Sep;11(3):238-250.e1
pubmed: 23659772
Biochem Pharmacol. 2010 Dec 15;80(12):1833-43
pubmed: 20654584
Urol Oncol. 2004 Sep-Oct;22(5):415-20
pubmed: 15464923
Prostate. 1996 Apr;28(4):251-65
pubmed: 8602401
Breast Cancer Res. 2001;3(5):323-7
pubmed: 11597322
Biomaterials. 2017 Oct;141:272-283
pubmed: 28704679
Nutr Cancer. 2012;64(2):173-97
pubmed: 22149093
Nutr Metab (Lond). 2019 Apr 11;16:24
pubmed: 31011360
Chem Soc Rev. 2015 Mar 21;44(6):1561-84
pubmed: 25176037
Chem Rev. 2014 Jan 8;114(1):815-62
pubmed: 24102434
J Control Release. 2021 Jan 10;329:76-86
pubmed: 33245955
J Oncol. 2012;2012:271063
pubmed: 22690215
Prostate. 2001 Jun 1;47(4):293-303
pubmed: 11398177
Nanoscale. 2016 Mar 7;8(9):5126-38
pubmed: 26875690
Br J Cancer. 2014 Mar 18;110(6):1645-54
pubmed: 24504368
Nano Lett. 2020 Feb 12;20(2):1362-1369
pubmed: 31928014
Adv Drug Deliv Rev. 2012 Oct;64(13):1417-35
pubmed: 22982406
Anal Bioanal Chem. 2019 Jul;411(19):4313-4326
pubmed: 30758528
J Carcinog. 2007 Mar 16;6:3
pubmed: 17367528
Eur J Clin Nutr. 2007 Mar;61(3):295-303
pubmed: 16929242
Mol Cancer Ther. 2008 Sep;7(9):2609-20
pubmed: 18790744
Nano Converg. 2016;3(1):1
pubmed: 28191411
Prostate. 2008 Jan 1;68(1):61-71
pubmed: 18008333
Acta Biochim Pol. 2005;52(3):609-27
pubmed: 16175236
Arch Biochem Biophys. 2019 May 30;667:36-48
pubmed: 31047869
Nutr J. 2015 Jun 19;14:62
pubmed: 26085034
Carcinogenesis. 2007 Jun;28(6):1188-96
pubmed: 17151092
Int J Cancer. 2007 Feb 15;120(4):719-33
pubmed: 17163421
Carbohydr Polym. 2020 Mar 1;231:115702
pubmed: 31888827
Int J Pharm. 2021 May 15;601:120571
pubmed: 33812967
Asian J Androl. 2018 Sep 7;:
pubmed: 30198495
Drug Deliv Transl Res. 2015 Jun;5(3):231-42
pubmed: 25787731
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nat Rev Cancer. 2004 Oct;4(10):806-13
pubmed: 15510161
World J Mens Health. 2019 Sep;37(3):288-295
pubmed: 30209899
Biomed Pharmacother. 2020 Jul;127:110181
pubmed: 32416561
Biochim Biophys Acta Biomembr. 2020 Sep 1;1862(9):183361
pubmed: 32422137
Front Cell Dev Biol. 2021 Nov 05;9:745177
pubmed: 34805155
Theranostics. 2016 Aug 07;6(11):1887-98
pubmed: 27570558
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Biochim Biophys Acta. 2004 Feb 10;1661(1):47-60
pubmed: 14967474
Nutrition. 2016 Feb;32(2):174-8
pubmed: 26706021
Biomed Res Int. 2014;2014:498420
pubmed: 25165707
J Cell Biochem. 2012 Feb;113(2):553-62
pubmed: 21938742
Mol Pharmacol. 2007 Jul;72(1):29-39
pubmed: 17395690
Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8999-9011
pubmed: 30575945
Sci Rep. 2016 Feb 15;6:20867
pubmed: 26875783
Front Immunol. 2019 Feb 01;10:135
pubmed: 30774635
Mol Nutr Food Res. 2016 Jun;60(6):1427-36
pubmed: 26820911
Gene. 2017 Oct 5;631:29-38
pubmed: 28843521
ACS Appl Mater Interfaces. 2019 Oct 23;11(42):38537-38554
pubmed: 31553876
Urology. 2001 Nov;58(5):651-6
pubmed: 11711330
Nutrients. 2015 Jan 06;7(1):321-34
pubmed: 25569626
Int J Mol Sci. 2013 Jul 12;14(7):14620-46
pubmed: 23857058
J Control Release. 2007 Oct 8;122(3):365-74
pubmed: 17574288
Cold Spring Harb Perspect Med. 2018 Jun 1;8(6):
pubmed: 29101113
Biomed Pharmacother. 2020 Sep;129:110459
pubmed: 32768949
Oncol Rep. 2017 Mar;37(3):1653-1661
pubmed: 28098869
Expert Opin Investig Drugs. 2013 Dec;22(12):1613-26
pubmed: 24050482
J Control Release. 2013 Apr 10;167(1):1-10
pubmed: 23352910
Biochim Biophys Acta. 2000 Jun 1;1466(1-2):11-5
pubmed: 10825426
Eur J Med Chem. 2018 Jan 20;144:874-886
pubmed: 29329071
Adv Pharm Bull. 2017 Apr;7(1):3-9
pubmed: 28507932
Mol Cancer Ther. 2005 Feb;4(2):233-41
pubmed: 15713895
Front Endocrinol (Lausanne). 2022 Feb 01;12:802447
pubmed: 35178029
Anticancer Res. 2018 Nov;38(11):6069-6083
pubmed: 30396921
Cancer Res. 1994 Nov 15;54(22):5841-7
pubmed: 7954412
Biomaterials. 2005 Oct;26(29):5818-26
pubmed: 15949547
Oncotarget. 2014 May 15;5(9):2462-74
pubmed: 24770864
Toxicol Appl Pharmacol. 2008 May 15;229(1):33-43
pubmed: 18275980
Acta Pharmacol Sin. 2012 Apr;33(4):531-41
pubmed: 22426696
Prostate Cancer Prostatic Dis. 2006;9(2):147-52
pubmed: 16389264
J Natl Cancer Inst. 2014 Feb;106(2):djt430
pubmed: 24463248
Expert Opin Ther Pat. 2018 Dec;28(12):875-882
pubmed: 30484340
Curr Drug Metab. 2012 Jan;13(1):120-8
pubmed: 21892919
Biomaterials. 2014 Oct;35(30):8635-48
pubmed: 25028336
Biochim Biophys Acta. 2016 Dec;1858(12):3050-3060
pubmed: 27677212
Anticancer Res. 2013 Jan;33(1):39-44
pubmed: 23267126
Biochem Biophys Res Commun. 2008 Sep 5;373(4):618-23
pubmed: 18602367
Mol Clin Oncol. 2019 Feb;10(2):191-204
pubmed: 30680195
Biomed Pharmacother. 2019 Sep;117:109121
pubmed: 31252265
Nanomedicine. 2010 Apr;6(2):245-56
pubmed: 19699321
J Fungi (Basel). 2021 Sep 06;7(9):
pubmed: 34575766
Clin Genitourin Cancer. 2016 Aug;14(4):265-70
pubmed: 26827258
Food Chem. 2013 Dec 1;141(3):1923-33
pubmed: 23870911
Asian Pac J Cancer Prev. 2013;14(5):2859-63
pubmed: 23803044
Acta Pharm Sin B. 2014 Jun;4(3):173-81
pubmed: 26579381
Int J Cancer. 2002 Jun 20;99(6):846-52
pubmed: 12115487
Biomed Pharmacother. 2017 May;89:689-695
pubmed: 28267672
Adv Exp Med Biol. 2018;1095:1-14
pubmed: 30229546
Nanoscale. 2019 Mar 28;11(13):5822-5838
pubmed: 30888379
Cancer Res. 2006 Jan 15;66(2):613-21
pubmed: 16423986
J Control Release. 2017 Aug 28;260:111-123
pubmed: 28583444
Cancer Res. 2004 May 15;64(10):3653-60
pubmed: 15150125
J Drug Target. 2013 Dec;21(10):1001-11
pubmed: 24151835
Mol Immunol. 2018 Jun;98:8-12
pubmed: 29128232
Int J Med Sci. 2014 Jul 02;11(9):948-54
pubmed: 25076850
Mol Cancer Ther. 2009 Jun;8(6):1684-91
pubmed: 19509250
Front Bioeng Biotechnol. 2021 Sep 09;9:705886
pubmed: 34568298
Biol Pharm Bull. 2017;40(1):1-10
pubmed: 28049940
Environ Health Perspect. 2004 Jun;112(8):879-82
pubmed: 15175176
Int J Oncol. 2017 Jul;51(1):223-234
pubmed: 28560383
J Cell Mol Med. 2012 Nov;16(11):2631-6
pubmed: 22452992
Nanotechnol Sci Appl. 2016 Aug 19;9:49-67
pubmed: 27578966
Nat Rev Cancer. 2011 Feb;11(2):85-95
pubmed: 21258394
Molecules. 2019 Jul 10;24(14):
pubmed: 31295906
J Clin Oncol. 2011 Sep 20;29(27):3686-94
pubmed: 21844499
Sci Rep. 2017 Jul 19;7(1):5901
pubmed: 28724986
Mol Nutr Food Res. 2008 Jun;52(6):646-54
pubmed: 18537129
Expert Opin Biol Ther. 2004 Nov;4(11):1735-47
pubmed: 15500402
Biomed Pharmacother. 2016 Dec;84:177-184
pubmed: 27657825
Mol Cancer Ther. 2008 Sep;7(9):2703-12
pubmed: 18765827
Int J Oncol. 2011 Oct;39(4):771-9
pubmed: 21743964
Nanomaterials (Basel). 2021 Mar 19;11(3):
pubmed: 33808823
Biochem Biophys Res Commun. 2005 Feb 18;327(3):866-70
pubmed: 15649425
Oncotarget. 2017 Apr 28;8(39):65022-65041
pubmed: 29029409
Int J Nanomedicine. 2019 Jun 18;14:4413-4428
pubmed: 31417252
Bioorg Med Chem. 2021 Jul 15;42:116249
pubmed: 34126286
J Pathol. 2004 Jan;202(1):50-9
pubmed: 14694521
BJU Int. 2005 Jun;95(9):1320-6
pubmed: 15892825
Molecules. 2016 May 12;21(5):
pubmed: 27187332
J Biol Chem. 2000 Apr 14;275(15):10761-6
pubmed: 10753867
Materials (Basel). 2022 Jan 21;15(3):
pubmed: 35160749
PLoS One. 2017 Mar 31;12(3):e0174935
pubmed: 28362855
Onco Targets Ther. 2016 May 26;9:3085-94
pubmed: 27307749
Clin Cancer Res. 2013 Mar 15;19(6):1335-9
pubmed: 23300275
J Control Release. 2017 Feb 10;247:134-144
pubmed: 28069554
Biochim Biophys Acta. 1992 Jul 8;1108(1):40-8
pubmed: 1643080
Biomed Pharmacother. 2019 Apr;112:108612
pubmed: 30798142
Oncotarget. 2016 Jul 16;8(36):60025-60035
pubmed: 28947951
Eur J Pharm Biopharm. 2018 Sep;130:1-10
pubmed: 29908938
Diagn Pathol. 2014 May 27;9:98
pubmed: 24886405
J Membr Biol. 2013 Apr;246(4):307-14
pubmed: 23417033
Future Sci OA. 2022 Feb 11;8(3):FSO784
pubmed: 35251698
Chin J Cancer. 2017 Jun 24;36(1):52
pubmed: 28646911
ACS Appl Mater Interfaces. 2020 Jun 24;12(25):28047-28056
pubmed: 32478501
Carcinogenesis. 2007 Mar;28(3):713-23
pubmed: 17065200
Nutrients. 2020 Mar 26;12(4):
pubmed: 32224910
Gene. 2016 Jul 1;585(1):93-99
pubmed: 27032461
Life Sci. 2019 Mar 1;220:136-146
pubmed: 30710640
Biochem Biophys Res Commun. 2018 Sep 5;503(2):1057-1062
pubmed: 29935187
Acta Pharm Sin B. 2019 Jan;9(1):36-48
pubmed: 30766776
Curr Cancer Drug Targets. 2016;16(5):455-65
pubmed: 26638886
Carcinogenesis. 2020 Aug 12;41(8):1145-1157
pubmed: 31805186
Biomaterials. 2018 Jun;166:13-26
pubmed: 29529479
Int J Nanomedicine. 2016 Jul 28;11:3533-44
pubmed: 27555773
BMC Cancer. 2009 Mar 30;9:99
pubmed: 19331692
Phytother Res. 2021 Jul;35(7):3509-3532
pubmed: 33580629
Ther Deliv. 2017 Mar;8(5):331-342
pubmed: 28361613
Int Urol Nephrol. 2015 Jun;47(6):965-70
pubmed: 25971353
Chem Rev. 2019 Jan 23;119(2):1519-1624
pubmed: 30489072
Carcinogenesis. 2008 May;29(5):1049-56
pubmed: 18359761
Pharm Res. 2010 Jun;27(6):1115-27
pubmed: 20309614
Cell Cycle. 2008 Nov 1;7(21):3320-6
pubmed: 18948740
Oncol Rep. 2013 Dec;30(6):2804-10
pubmed: 24085108
Cancers (Basel). 2013 Jun 19;5(2):726-38
pubmed: 24216999
Int J Oncol. 2010 Sep;37(3):533-9
pubmed: 20664922
J Biophotonics. 2021 Jan;14(1):e202000200
pubmed: 32827206
Lancet Oncol. 2012 Oct;13(10):983-92
pubmed: 22995653
J Pharmacol Exp Ther. 2002 Aug;302(2):645-50
pubmed: 12130727
Dev Biol. 2003 Jan 15;253(2):165-74
pubmed: 12645922
Int J Mol Sci. 2020 Mar 26;21(7):
pubmed: 32225036
Adv Drug Deliv Rev. 2002 Sep 13;54(5):695-713
pubmed: 12204599
Nutr Cancer. 2018 Jul;70(5):697-709
pubmed: 29764209
BJU Int. 2012 Jul;110(2 Pt 2):E99-104
pubmed: 22177289
Colloids Surf B Biointerfaces. 2018 Nov 1;171:24-30
pubmed: 30005287
Biomater Sci. 2018 Dec 18;7(1):419-428
pubmed: 30500018
Biomedicines. 2020 Sep 12;8(9):
pubmed: 32932737
Mol Med Rep. 2015 May;11(5):3920-4
pubmed: 25572870
Exp Biol Med (Maywood). 2002 Nov;227(10):852-9
pubmed: 12424325
Am J Clin Pathol. 1968 Mar;49(3):347-57
pubmed: 5645095
Adv Ther. 2018 Sep;35(9):1285-1294
pubmed: 30097885
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Prev Res (Phila). 2015 May;8(5):365-74
pubmed: 25712054
Carcinogenesis. 2008 Apr;29(4):816-23
pubmed: 18283040
Jpn J Clin Oncol. 2002 Aug;32(8):296-300
pubmed: 12411567
Cancer Res. 2008 Dec 1;68(23):9918-27
pubmed: 19047173
Cancer Lett. 2015 May 1;360(2):205-12
pubmed: 25684664
Oncol Rep. 2017 Feb;37(2):1253-1260
pubmed: 28075466
Biochim Biophys Acta. 2016 Feb;1858(2):189-96
pubmed: 26607013
Food Chem Toxicol. 2013 Oct;60:424-30
pubmed: 23939040
J Cell Biochem. 2006 Oct 1;99(2):362-72
pubmed: 16619264
Oncol Rep. 2020 Sep;44(3):1255-1265
pubmed: 32705219
Biomed Pharmacother. 2019 Aug;116:109006
pubmed: 31152925
Tissue Cell. 2022 Jun;76:101805
pubmed: 35487055
Anticancer Res. 2019 Jul;39(7):3469-3485
pubmed: 31262871
J Biomol Struct Dyn. 2021 Sep;39(14):5182-5208
pubmed: 32643549
Arch Biochem Biophys. 2015 Apr 15;572:28-35
pubmed: 25711533
Pharmacol Res. 2019 Dec;150:104454
pubmed: 31526871
Cancer. 2003 Apr 15;97(8):2035-42
pubmed: 12673735
J Steroid Biochem Mol Biol. 2017 Feb;166:28-37
pubmed: 27133384
Carcinogenesis. 2014 Oct;35(10):2321-30
pubmed: 25023990
Mol Pharm. 2012 Jul 2;9(7):2103-10
pubmed: 22670575
AAPS PharmSciTech. 2020 May 17;21(5):138
pubmed: 32419093
Front Pharmacol. 2019 Dec 06;10:1336
pubmed: 31866857
Drug Des Devel Ther. 2017 Sep 05;11:2631-2642
pubmed: 28919713
Int J Med Sci. 2015 Jan 01;12(1):63-71
pubmed: 25552920
J Control Release. 2021 Jul 10;335:306-319
pubmed: 34081995
Int J Urol. 2005 Jan;12(1):73-80
pubmed: 15661057
Evid Based Complement Alternat Med. 2017;2017:1691568
pubmed: 28133488
Acta Biomater. 2021 Oct 15;134:57-78
pubmed: 34364016
Int J Mol Sci. 2010 Apr 15;11(4):1759-76
pubmed: 20480040
Environ Sci Process Impacts. 2013 Jan;15(1):103-22
pubmed: 24592431
Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):113-25
pubmed: 20456930
Environ Sci Pollut Res Int. 2021 Nov;28(42):59570-59593
pubmed: 34510341
J Control Release. 2018 May 10;277:1-13
pubmed: 29501721
J Natl Cancer Inst. 2009 Aug 19;101(16):1141-55
pubmed: 19638505
J Drug Target. 2020 Mar;28(3):225-244
pubmed: 31339374